IGF1R and Alzheimer disease: Among relevant protein targets with the 85 related pathways, AKT, IL-6, IL-1β, caspase 3, INS, GSK3β, TLR4, and IGF1R were the key target nodes with the top degree, indicating that they may be the most likely targets for AD therapy of KXS.